A multidisciplinary panel discussion focused on increasing awareness of Metabolic Dysfunction-Associated Steatohepatitis (MASH), a critical but often overlooked liver health disease. This session will bring together leading experts in hepatology, metabolic health, and patient advocacy for a discussion into the impact of MASH, and diagnostic and treatment advancements to emphasize how comprehensive care can lead to improved health outcomes, reduce healthcare costs, and enhance the quality of life for patients. 

Made possible through the generous support of our Diamond Sponsor: